{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T04:22:57Z","timestamp":1728447777264},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2004,11,11]],"date-time":"2004-11-11T00:00:00Z","timestamp":1100131200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2004,11,11]],"date-time":"2004-11-11T00:00:00Z","timestamp":1100131200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2004,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Background<\/jats:title>\n                        <jats:p>Although percutaneous coronary intervention (PCI) is becoming the standard therapy in ST-segment elevation myocardial infarction (STEMI), to date most patients, even in developed countries, are reperfused with intravenous thrombolysis or do not receive a reperfusion therapy at all. In the post-lysis period these patients are at high risk for recurrent ischemic events. Early identification of these patients is mandatory as this subgroup could possibly benefit from an angioplasty of the infarct-related artery.<\/jats:p>\n                        <jats:p>Since viability seems to be related to ischemic adverse events, we initiated a clinical trial to investigate the benefits of PCI with stenting of the infarct-related artery in patients with viability detected early after acute myocardial infarction.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>The VIAMI-study is designed as a prospective, multicenter, randomized, controlled clinical trial. Patients who are hospitalized with an acute myocardial infarction and who did not have primary or rescue PCI, undergo viability testing by low-dose dobutamine echocardiography (LDDE) within 3 days of admission. Consequently, patients with demonstrated viability are randomized to an invasive or conservative strategy. In the invasive strategy patients undergo coronary angiography with the intention to perform PCI with stenting of the infarct-related coronary artery and concomitant use of abciximab. In the conservative group an ischemia-guided approach is adopted (standard optimal care).<\/jats:p>\n                        <jats:p>The primary end point is the composite of death from any cause, reinfarction and unstable angina during a follow-up period of three years.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusion<\/jats:title>\n                        <jats:p>The primary objective of the VIAMI-trial is to demonstrate that angioplasty of the infarct-related coronary artery with stenting and concomitant use of abciximab results in a clinically important risk reduction of future cardiac events in patients with viability in the infarct-area, detected early after myocardial infarction.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/1468-6708-5-11","type":"journal-article","created":{"date-parts":[[2004,11,13]],"date-time":"2004-11-13T07:32:59Z","timestamp":1100331179000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Early and long-term outcome of elective stenting of the infarct-related artery in patients with viability in the infarct-area: Rationale and design of the Viability-guided Angioplasty after acute Myocardial Infarction-trial (The VIAMI-trial)"],"prefix":"10.1186","volume":"5","author":[{"given":"Ramon B","family":"van Loon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerrit","family":"Veen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Otto","family":"Kamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean GF","family":"Bronzwaer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cees A","family":"Visser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frans C","family":"Visser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,11,11]]},"reference":[{"key":"118_CR1","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/0735-1097(90)90575-A","volume":"16","author":"RM Gunnar","year":"1990","unstructured":"Gunnar RM, Passamani ER, Bourdillon PD, Pitt B, Dixon DW, Rapaport E, Fuster V, Reeves TJ, Karp RB, Russell ROJ, .: Guidelines for the early management of patients with acute myocardial infarction. A report of the American College of Cardiology\/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee to Develop Guidelines for the Early Management of Patients with Acute Myocardial Infarction). J Am Coll Cardiol. 1990, 16: 249-292.","journal-title":"J Am Coll Cardiol"},{"key":"118_CR2","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1016\/j.jacc.2004.07.014","volume":"44","author":"EM Antman","year":"2004","unstructured":"Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SCJ, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK, Ornato JP: ACC\/AHA guidelines for the management of patients with ST-elevation myocardial infarction; A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of patients with acute myocardial infarction). J Am Coll Cardiol. 2004, 44: E1-E211. 10.1016\/j.jacc.2004.07.014.","journal-title":"J Am Coll Cardiol"},{"key":"118_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0140-6736(03)12113-7","volume":"361","author":"EC Keeley","year":"2003","unstructured":"Keeley EC, Boura JA, Grines CL: Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003, 361: 13-20. 10.1016\/S0140-6736(03)12113-7.","journal-title":"Lancet"},{"key":"118_CR4","first-page":"28","volume":"24","author":"WF Van de","year":"2003","unstructured":"Van de WF, Ardissino D, Betriu A, Cokkinos DV, Falk E, Fox KA, Julian D, Lengyel M, Neumann FJ, Ruzyllo W, Thygesen C, Underwood SR, Vahanian A, Verheugt FW, Wijns W: Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J. 2003, 24: 28-66.","journal-title":"Eur Heart J"},{"key":"118_CR5","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1053\/euhj.2002.3193","volume":"23","author":"D Hasdai","year":"2002","unstructured":"Hasdai D, Behar S, Wallentin L, Danchin N, Gitt AK, Boersma E, Fioretti PM, Simoons ML, Battler A: A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). Eur Heart J. 2002, 23: 1190-1201. 10.1053\/euhj.2002.3193.","journal-title":"Eur Heart J"},{"key":"118_CR6","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1001\/jama.286.11.1356","volume":"286","author":"DA Morrow","year":"2001","unstructured":"Morrow DA, Antman EM, Parsons L, de Lemos JA, Cannon CP, Giugliano RP, McCabe CH, Barron HV, Braunwald E: Application of the TIMI risk score for ST-elevation MI in the National Registry of Myocardial Infarction 3. JAMA. 2001, 286: 1356-1359. 10.1001\/jama.286.11.1356.","journal-title":"JAMA"},{"key":"118_CR7","doi-asserted-by":"crossref","unstructured":"GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. Lancet. 1990, 336: 65-71.","DOI":"10.1016\/0140-6736(90)91589-3"},{"key":"118_CR8","doi-asserted-by":"crossref","unstructured":"ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group. Lancet. 1992, 339: 753-770.","DOI":"10.1016\/0140-6736(92)91893-D"},{"key":"118_CR9","doi-asserted-by":"crossref","unstructured":"The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. The GUSTO Angiographic Investigators. N Engl J Med. 1993, 329: 1615-1622. 10.1056\/NEJM199311253292204.","DOI":"10.1056\/NEJM199311253292204"},{"key":"118_CR10","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1161\/01.CIR.87.5.1524","volume":"87","author":"A Meijer","year":"1993","unstructured":"Meijer A, Verheugt FW, Werter CJ, Lie KI, van der Pol JM, van Eenige MJ: Aspirin versus coumadin in the prevention of reocclusion and recurrent ischemia after successful thrombolysis: a prospective placebo-controlled angiographic study. Results of the APRICOT Study. Circulation. 1993, 87: 1524-1530.","journal-title":"Circulation"},{"key":"118_CR11","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/0735-1097(93)90754-O","volume":"22","author":"G Veen","year":"1993","unstructured":"Veen G, Meyer A, Verheugt FW, Werter CJ, de Swart H, Lie KI, van der Pol JM, Michels HR, van Eenige MJ: Culprit lesion morphology and stenosis severity in the prediction of reocclusion after coronary thrombolysis: angiographic results of the APRICOT study. Antithrombotics in the Prevention of Reocclusion in Coronary Thrombolysis. J Am Coll Cardiol. 1993, 22: 1755-1762.","journal-title":"J Am Coll Cardiol"},{"key":"118_CR12","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1161\/01.CIR.90.4.1706","volume":"90","author":"A Meijer","year":"1994","unstructured":"Meijer A, Verheugt FW, van Eenige MJ, Werter CJ: Left ventricular function at 3 months after successful thrombolysis. Impact of reocclusion without reinfarction on ejection fraction, regional function, and remodeling. Circulation. 1994, 90: 1706-1714.","journal-title":"Circulation"},{"key":"118_CR13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1161\/01.CIR.95.1.111","volume":"95","author":"F Nijland","year":"1997","unstructured":"Nijland F, Kamp O, Verheugt FW, Veen G, Visser CA: Long-term implications of reocclusion on left ventricular size and function after successful thrombolysis for first anterior myocardial infarction. Circulation. 1997, 95: 111-117.","journal-title":"Circulation"},{"key":"118_CR14","doi-asserted-by":"crossref","unstructured":"Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial. The TIMI Study Group. N Engl J Med. 1989, 320: 618-627.","DOI":"10.1056\/NEJM198903093201002"},{"key":"118_CR15","doi-asserted-by":"crossref","unstructured":"SWIFT trial of delayed elective intervention v conservative treatment after thrombolysis with anistreplase in acute myocardial infarction. SWIFT (Should We Intervene Following Thrombolysis?) Trial Study Group. BMJ. 1991, 302: 555-560.","DOI":"10.1136\/bmj.302.6776.555"},{"key":"118_CR16","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S0735-1097(86)80172-3","volume":"8","author":"R Erbel","year":"1986","unstructured":"Erbel R, Pop T, Henrichs KJ, von Olshausen K, Schuster CJ, Rupprecht HJ, Steuernagel C, Meyer J: Percutaneous transluminal coronary angioplasty after thrombolytic therapy: a prospective controlled randomized trial. J Am Coll Cardiol. 1986, 8: 485-495.","journal-title":"J Am Coll Cardiol"},{"key":"118_CR17","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1056\/NEJM198712243172601","volume":"317","author":"AD Guerci","year":"1987","unstructured":"Guerci AD, Gerstenblith G, Brinker JA, Chandra NC, Gottlieb SO, Bahr RD, Weiss JL, Shapiro EP, Flaherty JT, Bush DE, .: A randomized trial of intravenous tissue plasminogen activator for acute myocardial infarction with subsequent randomization to elective coronary angioplasty. N Engl J Med. 1987, 317: 1613-1618.","journal-title":"N Engl J Med"},{"key":"118_CR18","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1161\/01.CIR.81.5.1457","volume":"81","author":"WJ Rogers","year":"1990","unstructured":"Rogers WJ, Baim DS, Gore JM, Brown BG, Roberts R, Williams DO, Chesebro JH, Babb JD, Sheehan FH, Wackers FJ, .: Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II-A trial. Circulation. 1990, 81: 1457-1476.","journal-title":"Circulation"},{"key":"118_CR19","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0140-6736(88)91062-8","volume":"1","author":"ML Simoons","year":"1988","unstructured":"Simoons ML, Arnold AE, Betriu A, de Bono DP, Col J, Dougherty FC, von Essen R, Lambertz H, Lubsen J, Meier B, .: Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty. Lancet. 1988, 1: 197-203. 10.1016\/S0140-6736(88)91062-8.","journal-title":"Lancet"},{"key":"118_CR20","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1056\/NEJM198709033171001","volume":"317","author":"EJ Topol","year":"1987","unstructured":"Topol EJ, Califf RM, George BS, Kereiakes DJ, Abbottsmith CW, Candela RJ, Lee KL, Pitt B, Stack RS, O'Neill WW: A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med. 1987, 317: 581-588.","journal-title":"N Engl J Med"},{"key":"118_CR21","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/0002-9343(87)90940-5","volume":"83","author":"VF Froelicher","year":"1987","unstructured":"Froelicher VF, Perdue S, Pewen W, Risch M: Application of meta-analysis using an electronic spread sheet to exercise testing in patients after myocardial infarction. Am J Med. 1987, 83: 1045-1054. 10.1016\/0002-9343(87)90940-5.","journal-title":"Am J Med"},{"key":"118_CR22","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.1161\/01.CIR.96.9.2932","volume":"96","author":"S Basu","year":"1997","unstructured":"Basu S, Senior R, Raval U, Lahiri A: Superiority of nitrate-enhanced 201Tl over conventional redistribution 201Tl imaging for prognostic evaluation after myocardial infarction and thrombolysis [see comments]. Circulation. 1997, 96: 2932-2937.","journal-title":"Circulation"},{"key":"118_CR23","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0002-9149(00)01359-X","volume":"87","author":"R Bigi","year":"2001","unstructured":"Bigi R, Desideri A, Bax JJ, Galati A, Coletta C, Fiorentini C, Fioretti PM: Prognostic interaction between viability and residual myocardial ischemia by dobutamine stress echocardiography in patients with acute myocardial infarction and mildly impaired left ventricular function. Am J Cardiol. 2001, 87: 283-288. 10.1016\/S0002-9149(00)01359-X.","journal-title":"Am J Cardiol"},{"key":"118_CR24","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/S0002-9149(98)00143-X","volume":"81","author":"JM Huitink","year":"1998","unstructured":"Huitink JM, Visser FC, Bax JJ, van Lingen A, Groenveld AB, Teule GJ, Visser CA: Predictive value of planar 18F-fluorodeoxyglucose imaging for cardiac events in patients after acute myocardial infarction. Am J Cardiol. 1998, 81: 1072-1077. 10.1016\/S0002-9149(98)00143-X.","journal-title":"Am J Cardiol"},{"key":"118_CR25","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1161\/01.CIR.90.6.2687","volume":"90","author":"KS Lee","year":"1994","unstructured":"Lee KS, Marwick TH, Cook SA, Go RT, Fix JS, James KB, Sapp SK, MacIntyre WJ, Thomas JD: Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization. Circulation. 1994, 90: 2687-2694.","journal-title":"Circulation"},{"key":"118_CR26","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0735-1097(98)81370-3","volume":"31","author":"POVIPWGNCMRIESC Marzullo","year":"1998","unstructured":"Marzullo POVIPWGNCMRIESC, CNR Institute of Clinical Physiology PI: Viability Impact on Prognosis (VIP): Results in 622 patients. J Am Coll Cardiol. 1998, 31: 167-167. 10.1016\/S0735-1097(98)81370-3.","journal-title":"J Am Coll Cardiol"},{"key":"118_CR27","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/S0002-9149(01)01968-3","volume":"88","author":"F Nijland","year":"2001","unstructured":"Nijland F, Kamp O, Verhorst PM, de Voogt WG, Visser CA: In-hospital and long-term prognostic value of viable myocardium detected by dobutamine echocardiography early after acute myocardial infarction and its relation to indicators of left ventricular systolic dysfunction. Am J Cardiol. 2001, 88: 949-955. 10.1016\/S0002-9149(01)01968-3.","journal-title":"Am J Cardiol"},{"key":"118_CR28","first-page":"195","volume":"38","author":"M Petretta","year":"1997","unstructured":"Petretta M, Cuocolo A, Bonaduce D, Nicolai E, Cardei S, Berardino S, Ianniciello A, Apicella C, Bianchi V, Salvatore M: Incremental prognostic value of thallium reinjection after stress- redistribution imaging in patients with previous myocardial infarction and left ventricular dysfunction. J Nucl Med. 1997, 38: 195-200.","journal-title":"J Nucl Med"},{"key":"118_CR29","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/S0735-1097(98)00243-5","volume":"32","author":"M Previtali","year":"1998","unstructured":"Previtali M, Fetiveau R, Lanzarini L, Cavalotti C, Klersy C: Prognostic value of myocardial viability and ischemia detected by dobutamine stress echocardiography early after acute myocardial infarction treated with thrombolysis. J Am Coll Cardiol. 1998, 32: 380-386. 10.1016\/S0735-1097(98)00243-5.","journal-title":"J Am Coll Cardiol"},{"key":"118_CR30","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S0735-1097(99)00232-6","volume":"34","author":"A Salustri","year":"1999","unstructured":"Salustri A, Ciavatti M, Seccareccia F, Palamara A: Prediction of cardiac events after uncomplicated acute myocardial infarction by clinical variables and dobutamine stress test. J Am Coll Cardiol. 1999, 34: 435-440. 10.1016\/S0735-1097(99)00232-6.","journal-title":"J Am Coll Cardiol"},{"key":"118_CR31","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/S0735-1097(96)00484-6","volume":"29","author":"R Sicari","year":"1997","unstructured":"Sicari R, Picano E, Landi P, Pingitore A, Bigi R, Coletta C, Heyman J, Casazza F, Previtali M, Mathias WJ, Dodi C, Minardi G, Lowenstein J, Garyfallidis X, Cortigiani L, Morales MA, Raciti M: Prognostic value of dobutamine-atropine stress echocardiography early after acute myocardial infarction. Echo Dobutamine International Cooperative (EDIC) Study. J Am Coll Cardiol. 1997, 29: 254-260. 10.1016\/S0735-1097(96)00484-6.","journal-title":"J Am Coll Cardiol"},{"key":"118_CR32","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/S0002-9149(98)00973-4","volume":"83","author":"S Iskander","year":"1999","unstructured":"Iskander S, Iskandrian AE: Prognostic utility of myocardial viability assessment. Am J Cardiol. 1999, 83: 696-702, A7. 10.1016\/S0002-9149(98)00973-4.","journal-title":"Am J Cardiol"},{"key":"118_CR33","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1161\/01.CIR.95.6.1402","volume":"95","author":"ME Carlos","year":"1997","unstructured":"Carlos ME, Smart SC, Wynsen JC, Sagar KB: Dobutamine stress echocardiography for risk stratification after myocardial infarction [see comments]. Circulation. 1997, 95: 1402-1410.","journal-title":"Circulation"},{"key":"118_CR34","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1161\/01.CIR.98.11.1078","volume":"98","author":"E Picano","year":"1998","unstructured":"Picano E, Sicari R, Landi P, Cortigiani L, Bigi R, Coletta C, Galati A, Heyman J, Mattioli R, Previtali M, Mathias WJ, Dodi C, Minardi G, Lowenstein J, Seveso G, Pingitore A, Salustri A, Raciti M: Prognostic value of myocardial viability in medically treated patients with global left ventricular dysfunction early after an acute uncomplicated myocardial infarction: a dobutamine stress echocardiographic study. Circulation. 1998, 98: 1078-1084.","journal-title":"Circulation"},{"key":"118_CR35","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S0002-8703(99)70497-7","volume":"137","author":"BA Samad","year":"1999","unstructured":"Samad BA, Frick M, Hojer J, Urstad MJ: Early low-dose dobutamine echocardiography predicts late functional recovery after thrombolyzed acute myocardial infarction. Am Heart J. 1999, 137: 489-493.","journal-title":"Am Heart J"},{"key":"118_CR36","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/0735-1097(93)90407-R","volume":"22","author":"K Yoshida","year":"1993","unstructured":"Yoshida K, Gould KL: Quantitative relation of myocardial infarct size and myocardial viability by positron emission tomography to left ventricular ejection fraction and 3-year mortality with and without revascularization. J Am Coll Cardiol. 1993, 22: 984-997.","journal-title":"J Am Coll Cardiol"},{"key":"118_CR37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1136\/heart.87.1.17","volume":"87","author":"F Nijland","year":"2002","unstructured":"Nijland F, Kamp O, Verhorst PM, de Voogt WG, Bosch HG, Visser CA: Myocardial viability: impact on left ventricular dilatation after acute myocardial infarction. Heart. 2002, 87: 17-22. 10.1136\/heart.87.1.17.","journal-title":"Heart"},{"key":"118_CR38","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/S0735-1097(97)00352-5","volume":"30","author":"JJ Bax","year":"1997","unstructured":"Bax JJ, Wijns W, Cornel JH, Visser FC, Boersma E, Fioretti PM: Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: Comparison of pooled data. Journal of the American College of Cardiology. 1997, 30: 1451-1460. 10.1016\/S0735-1097(97)00352-5.","journal-title":"Journal of the American College of Cardiology"},{"key":"118_CR39","doi-asserted-by":"crossref","unstructured":"Platelet glycoprotein IIb\/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. The EPILOG Investigators. N Engl J Med. 1997, 336: 1689-1696. 10.1056\/NEJM199706123362401.","DOI":"10.1056\/NEJM199706123362401"},{"key":"118_CR40","doi-asserted-by":"crossref","unstructured":"Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb\/IIIa blockade. The EPISTENT Investigators. Evaluation of Platelet IIb\/IIIa Inhibitor for Stenting. Lancet. 1998, 352: 87-92.","DOI":"10.1016\/S0140-6736(98)06113-3"},{"key":"118_CR41","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1056\/NEJM200106213442503","volume":"344","author":"G Montalescot","year":"2001","unstructured":"Montalescot G, Barragan P, Wittenberg O, Ecollan P, Elhadad S, Villain P, Boulenc JM, Morice MC, Maillard L, Pansieri M, Choussat R, Pinton P: Platelet glycoprotein IIb\/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med. 2001, 344: 1895-1903. 10.1056\/NEJM200106213442503.","journal-title":"N Engl J Med"},{"key":"118_CR42","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","volume":"358","author":"SR Mehta","year":"2001","unstructured":"Mehta SR, Yusuf S, Peters RJ, Bertrand ME, Lewis BS, Natarajan MK, Malmberg K, Rupprecht H, Zhao F, Chrolavicius S, Copland I, Fox KA: Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet. 2001, 358: 527-533. 10.1016\/S0140-6736(01)05701-4.","journal-title":"Lancet"},{"key":"118_CR43","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","volume":"288","author":"SR Steinhubl","year":"2002","unstructured":"Steinhubl SR, Berger PB, Mann JTIII, Fry ET, DeLago A, Wilmer C, Topol EJ: Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA. 2002, 288: 2411-2420. 10.1001\/jama.288.19.2411.","journal-title":"JAMA"},{"key":"118_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0735-1097(88)90158-1","volume":"11","author":"AK Rao","year":"1988","unstructured":"Rao AK, Pratt C, Berke A, Jaffe A, Ockene I, Schreiber TL, Bell WR, Knatterud G, Robertson TL, Terrin ML: Thrombolysis in Myocardial-Infarction (Timi) Trial - Phase-I - Hemorrhagic Manifestations and Changes in Plasma-Fibrinogen and the Fibrinolytic System in Patients Treated with Recombinant Tissue Plasminogen-Activator and Streptokinase. Journal of the American College of Cardiology. 1988, 11: 1-11.","journal-title":"Journal of the American College of Cardiology"},{"key":"118_CR45","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S0002-9149(01)01591-0","volume":"88","author":"D Poldermans","year":"2001","unstructured":"Poldermans D, Sozzi FB, Bax JJ, Boersma E, Duncker DJ, Vourvouri E, Elhendy A, Valkema R, Roelandt JR: Influence of continuation of beta blockers during dobutamine stress echocardiography for the assessment of myocardial viability in patients with severe ischemic left ventricular dysfunction. Am J Cardiol. 2001, 88: 68-70. 10.1016\/S0002-9149(01)01591-0.","journal-title":"Am J Cardiol"},{"key":"118_CR46","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0002-8703(95)90436-0","volume":"130","author":"NJ Weissman","year":"1995","unstructured":"Weissman NJ, Levangie MW, Newell JB, Guerrero JL, Weyman AE, Picard MH: Effect of beta-adrenergic receptor blockade on the physiologic response to dobutamine stress echocardiography. Am Heart J. 1995, 130: 248-253. 10.1016\/0002-8703(95)90436-0.","journal-title":"Am Heart J"},{"key":"118_CR47","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/S0894-7317(89)80013-6","volume":"2","author":"NB Schiller","year":"1989","unstructured":"Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I, .: Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989, 2: 358-367.","journal-title":"J Am Soc Echocardiogr"}],"container-title":["Current Controlled Trials in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1468-6708-5-11.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/1468-6708-5-11\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1468-6708-5-11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1468-6708-5-11.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T10:30:55Z","timestamp":1728383455000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/1468-6708-5-11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11,11]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["118"],"URL":"https:\/\/doi.org\/10.1186\/1468-6708-5-11","relation":{},"ISSN":["1468-6708","1468-6694"],"issn-type":[{"type":"print","value":"1468-6708"},{"type":"electronic","value":"1468-6694"}],"subject":[],"published":{"date-parts":[[2004,11,11]]},"assertion":[{"value":"14 October 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2004","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2004","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"11"}}